HyperBio Therapeutics ApS — Credit Rating and Financial Key Figures
CVR number: 41244909
Stærmosevej 12, 7120 Vejle Øst
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 |
Net sales | ||||
Gross profit | -5 571.12 | -12 881.90 | -8 628.93 | -74.48 |
Employee benefit expenses | -40.00 | -60.00 | -55.00 | |
EBIT | -5 611.12 | -12 941.90 | -8 683.93 | -74.48 |
Other financial income | 6.96 | 7.04 | 16.54 | 155.20 |
Other financial expenses | -27.35 | - 486.05 | -1 338.46 | -1 330.82 |
Pre-tax profit | -5 631.52 | -13 420.91 | -10 005.85 | -1 250.10 |
Income taxes | 1 573.29 | 2 808.04 | 2 349.49 | 277.36 |
Net earnings | -4 058.23 | -10 612.87 | -7 656.37 | - 972.75 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|
Intangible assets total | ||||
Tangible assets total | ||||
Investments total | ||||
Long term receivables total | ||||
Inventories total | ||||
Current amounts owed by group member comp. | 1 573.29 | 3 089.55 | 2 313.43 | 277.36 |
Prepayments and accrued income | 3.28 | |||
Current other receivables | 39.84 | 67.00 | 135.69 | 12.39 |
Short term receivables total | 1 616.40 | 3 156.54 | 2 449.12 | 289.74 |
Cash and bank deposits | 10 419.68 | 19 670.96 | 13 222.62 | 14 364.28 |
Cash and cash equivalents | 10 419.68 | 19 670.96 | 13 222.62 | 14 364.28 |
Balance sheet total (assets) | 12 036.08 | 22 827.50 | 15 671.74 | 14 654.03 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|
Share capital | 40.00 | 40.00 | 40.00 | 48.00 |
Retained earnings | 15 000.00 | 15 941.77 | 5 328.90 | 1 664.53 |
Profit of the financial year | -4 058.23 | -10 612.87 | -7 656.37 | - 972.75 |
Shareholders equity total | 10 981.77 | 5 368.90 | -2 287.47 | 739.78 |
Non-current loans from credit institutions | 15 355.07 | |||
Non-current liabilities total | 15 355.07 | |||
Current loans from credit institutions | 0.99 | 0.57 | ||
Current trade creditors | 1 051.11 | 2 100.07 | 1 375.17 | 4.09 |
Current owed to group member | 16 583.47 | 13 910.15 | ||
Other non-interest bearing current liabilities | 3.20 | 2.47 | ||
Current liabilities total | 1 054.31 | 2 103.53 | 17 959.21 | 13 914.24 |
Balance sheet total (liabilities) | 12 036.08 | 22 827.50 | 15 671.74 | 14 654.03 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.